|
| 37883803 | Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease. | Blood Adv | 2024 |
| 36322937 | Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial. | Blood | 2023 |
| 37595029 | A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD. | Blood Adv | 2023 |
| 38066894 | The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally. | Hematology Am Soc Hematol Educ Program | 2023 |
| 37064181 | Silent infarction in sickle cell disease is associated with brain volume loss in excess of infarct volume. | Front Neurol | 2023 |
| 36709623 | Relapsed or refractory large B-cell lymphoma after chimeric antigen receptor T-cell therapy: Current challenges and therapeutic options. | Br J Haematol | 2023 |
| 36906277 | TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia. | Transplant Cell Ther | 2023 |
| 36791762 | NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022. | J Natl Compr Canc Netw | 2023 |
| 36350716 | Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapy. | Blood Adv | 2023 |
| 34286479 | Characterizing Intracranial Hemodynamics in Sickle Cell Anemia: Impact of Patient-Specific Viscosity. | Cardiovasc Eng Technol | 2022 |
| 35765247 | Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience. | Br J Haematol | 2022 |
| 35719004 | Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy. | Br J Haematol | 2022 |
| 35752546 | SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies. | Blood Rev | 2022 |
| 36310802 | Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic. | Antimicrob Steward Healthc Epidemiol | 2022 |
| 36013014 | Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy. | J Clin Med | 2022 |
| 35181561 | Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation. | Transplant Cell Ther | 2022 |
| 34971579 | Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial. | Lancet Haematol | 2022 |
| 35196384 | Sustainability of low maternal mortality in pregnant women with SCD in a low-resource setting. | Blood Adv | 2022 |
| 32281458 | Reduced oxygen extraction efficiency in sickle cell anemia patients with evidence of cerebral capillary shunting. | J Cereb Blood Flow Metab | 2021 |
| 33830027 | Systematic Review/Meta-Analysis on Efficacy of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease: An International Effort on Behalf of the Pediatric Diseases Working Party of European Society for Blood and Marrow Transplantation and the Sickle Cell Transplantation International Consortium. | Transplant Cell Ther | 2021 |
| 33643509 | Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant. | J Hematol | 2021 |
| 33840223 | Cerebral Hemodynamics and Executive Function in Sickle Cell Anemia. | Stroke | 2021 |
| 34537420 | Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis. | Transplant Cell Ther | 2021 |
| 34563875 | Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa. | Pediatr Neurol | 2021 |
| 33984165 | Low FEV<sub>1</sub> is associated with fetal death in pregnant women with sickle cell disease. | Am J Hematol | 2021 |
| 34055410 | Safety of 3 Tesla Magnetic Resonance Imaging in Patients with Sickle Cell Disease. | Radiol Res Pract | 2021 |
| 34304802 | Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. | Transplant Cell Ther | 2021 |
| 33190070 | Intracranial and Extracranial Vascular Stenosis as Risk Factors for Stroke in Sickle Cell Disease. | Pediatr Neurol | 2021 |
| 33127310 | Low rates of anti-recipient isohemagglutinins in ABO incompatible hematopoietic stem cell transplants. | Transfus Apher Sci | 2021 |
| 33236662 | Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial. | Pediatr Hematol Oncol | 2021 |
| 31595633 | Improvement in processing speed following haploidentical bone marrow transplant with posttransplant cytoxan in children and adolescents with sickle cell disease. | Pediatr Blood Cancer | 2020 |
| 33709085 | New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide. | EJHaem | 2020 |
| 31814164 | Cerebral hemodynamics and metabolism are similar in sickle cell disease patients with hemoglobin SS and Sβ<sup>0</sup> thalassemia phenotypes. | Am J Hematol | 2020 |
| 31906442 | World Health Organization's Growth Reference Overestimates the Prevalence of Severe Malnutrition in Children with Sickle Cell Anemia in Africa. | J Clin Med | 2020 |
| 31782875 | Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell disease. | Transpl Infect Dis | 2020 |
| 31992845 | Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma. | Bone Marrow Transplant | 2020 |
| 32095187 | Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone. | World J Oncol | 2020 |
| 32892842 | Transfusion support in patients with sickle cell disease. | Semin Hematol | 2020 |
| 32390196 | The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia. | Am J Hematol | 2020 |
| 32415792 | Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial. | Br J Haematol | 2020 |
| 32552526 | Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease. | Hematology | 2020 |
| 32243517 | The double-edged sword of AlloHCT for SCD. | Blood | 2020 |
| 32208487 | Phase 2 trial of montelukast for prevention of pain in sickle cell disease. | Blood Adv | 2020 |
| 32140894 | Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study. | Ann Hematol | 2020 |
| 32202252 | Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update. | Hematol Oncol Stem Cell Ther | 2020 |
| 32202247 | Proceedings of the meeting of the Pediatric Disease Working Party (PDWP) of the European group for Blood and Marrow Transplantation (EBMT) on sickle cell disease 16-17 May 2019, Regensburg, Germany. | Hematol Oncol Stem Cell Ther | 2020 |
| 32192979 | Using novel magnetic resonance imaging methods to predict stroke risk in individuals with sickle cell anemia. | Hematol Oncol Stem Cell Ther | 2020 |
| 32510680 | Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial. | Am J Hematol | 2020 |
| 29260615 | Preliminary evidence for cerebral capillary shunting in adults with sickle cell anemia. | J Cereb Blood Flow Metab | 2019 |
| 31809537 | End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. | Blood Adv | 2019 |